{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-021923","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.651886+00:00","generated_at":"2026-05-25T01:05:40.198148+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OptimizeRx appoints Stephen Silvestro as CEO effective March 10, 2025","bullets":["Stephen Silvestro, previously interim CEO and President, appointed permanent CEO as of March 10, 2025.","Silvestro receives $500,000 annual base salary, target bonus of 80%, and $1.0M one-time equity grant.","Silvestro joined OptimizeRx in 2019 as CCO; served as President from Oct 2023; prior roles at CCH Tagetik, Prognos Health, Decision Resources Group.","Board conducted rigorous search with executive search firm; unanimous decision to appoint Silvestro, per Chair Lynn Vos.","Silvestro aims to focus on customer centricity, recurring revenue model, and becoming a Rule of 40 company."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-021923","json":"https://secwatch.observer/filing/0001213900-25-021923.json","markdown":"https://secwatch.observer/filing/0001213900-25-021923.md","text":"https://secwatch.observer/filing/0001213900-25-021923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000121390025021923/0001213900-25-021923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000121390025021923/ea0233702-8k_optimize.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T01:05:40.198148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e940ec0454","claim":"Stephen Silvestro was appointed as Chief Executive Officer at OptimizeRx Corp.","evidence_excerpt":"announced that Stephen Silvestro has been appointed to serve as the Company’s Chief Executive Officer, effective as of March 10, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390025021923/0001213900-25-021923-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}